Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Pulmonary Arterial Hypertension (PAH) - Market Size is Expected to Be USD 9.9 Billion by 2025 - Research and Markets

Research and Markets
Posted on: 02 Aug 17

The "Pulmonary Arterial Hypertension (PAH) - Market Insights, Epidemiology and Market Forecast - 2025" drug pipelines has been added to Research and Markets' offering.

The report provides an overview of the disease and global market size of the Pulmonary Arterial Hypertension (PAH) for the 7MM (United States, Germany, France, Italy, Spain and UK). It covers the therapeutics market revenue; average cost of therapy, treatment practice and Pulmonary Arterial Hypertension (PAH) forecasted market share for ten years to 2025, segmented by seven major markets.

In addition, the report includes the historical and forecasted epidemiological data for the diagnosed prevalent cases of Pulmonary Arterial Hypertension (PAH) till 2025. The report provides a detailed analysis and in-depth coverage of both current and emerging therapies. The report also covers the unmet need, market barriers and drivers of the Pulmonary Arterial Hypertension (PAH) market.

Key Coverage and Benefits:

  • The report will help in developing business strategies by understanding the trends shaping and driving the global Pulmonary Arterial Hypertension (PAH) market.
  • Understanding the global historical and forecasted epidemiological data covering 7MM from 2015-2025.
  • Organize sales and marketing efforts by identifying the best opportunities for Pulmonary Arterial Hypertension (PAH) in US, Europe (Germany, Spain, Italy, France and United Kingdom) and Japan.
  • To understand the future market competition in the global Pulmonary Arterial Hypertension (PAH) market and Insightful review of the key market drivers and barriers.
  • The report also covers the detailed global historical and forecasted Pulmonary Arterial Hypertension (PAH) market covering United States, Europe (Germany, Spain, Italy, France and United Kingdom) and Japan from 2015-2025.

Key Topics Covered:

  • Report Introduction
  • Pulmonary Arterial Hypertension (PAH) Market Overview at a Glance
  • Total Market Share Distribution of Pulmonary Arterial Hypertension (PAH) for 7 MM in 2016
  • Total Market Share Distribution of Pulmonary Arterial Hypertension (PAH) for 7 MM in 2025
  • Pulmonary Arterial Hypertension (PAH)
  • Overview
  • Symptoms
  • Pathophysiology
  • Staging
  • Diagnosis
  • Treatment
  • Epidemiology and Patient Population
  • Treatment Algorithm
  • Treatment Guidelines/Practices
  • Marketed Drugs for Pulmonary Arterial Hypertension (PAH)
  • Drug 1: Company A
  • Drug 2: Company B
  • Drug 3: Company C
  • Drug 4: Company B
  • Overview of Total Pulmonary Arterial Hypertension (PAH) Market (2016 & 2025)
  • Pulmonary Arterial Hypertension (PAH): Country-Wise Market Analysis

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/9fqh7d/pulmonary

View source version on businesswire.com: http://www.businesswire.com/news/home/20170802006030/en/

Business Wire
www.businesswire.com

Last updated on: 02/08/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.